Slavoj Žižek is a Slovenian philosopher and writer whose vast catalogue of work has earned him celebrity status across the globe. A radical leftist, his work encompasses everything from psychoanalysis and political theory to art and film criticism.
Described as “the leading Hegelian of our time”, he speaks to Georgina Godwin about his latest book, ‘Hegel in a Wired Brain’, which is an evaluation of the German philosopher’s relevance in the 21st century that ties in with the 250th anniversary of his birth.
In celebration of the 250th anniversary of the birth of G.W.F. Hegel, Slavoj Žižek gives us a reading of the philosophical giant that changes our way of thinking about our new posthuman era. No ordinary study of Hegel, Hegel in a Wired Brain investigates what he might have had to say about the idea of the ‘wired brain’ – what happens when a direct link between our mental processes and a digital machine emerges. Žižek explores the phenomenon of a wired brain effect, and what might happen when we can share our thoughts directly with others. He hones in on the key question of how it shapes our experience and status as ‘free’ individuals and asks what it means to be human when a machine can read our minds.
With characteristic verve and enjoyment of the unexpected, Žižek connects Hegel to the world we live in now, shows why he is much more fun than anyone gives him credit for, and why the 21st century might just be Hegelian.
Raja Dhir is the co-founder of microbiome company Seed. Based in LA, Seed is a collective of scientists and doctors, researching how bacteria can improve human health and that of our planet. Its first product, a daily synbiotic, focuses on the stomach.
Raja Dhir is a life sciences entrepreneur and Co-Founder of Seed, a venture-backed microbiome company pioneering the application of bacteria for both human and planetary health. He leads Seed’s R&D, academic collaborations, technology development, clinical trial design, supply chain, and intellectual property strategy.
Together with Dr. Jacques Ravel, he Co-Chairs Seed’s Scientific Advisory Board–an interdisciplinary group of scientists and doctors who lead research teams and teach at institutions including the teaching hospital of Harvard Medical School and the Trial Innovation Unit of Mass. General Hospital (MGH). Raja has designed clinical trials with leading academic institutions including the teaching hospital of Harvard Medical School and the Trial Innovation Unit of Mass. General Hospital (MGH).
Raja has unique expertise translating scientific research for product development with a track record that includes patented inventions to stabilize sensitive compounds to improve alpha-diversity of the gut microbiome (derived from micro-algae) and most recently, the co-invention of microbial technologies to protect honeybee populations (Apis mellifera) from neonicotinoid pesticides and pathogen colonization. His work also includes biofermentation and scale-up for both facultative and strict anaerobic organisms.